基因组测序与功能分析鉴定与系统性红斑狼疮相关的MAP4K3/GLK胚系和体细胞变异
研究纳入181例SLE患者和250名非SLE个体,通过二代测序鉴定GLK基因变异,发现58例SLE患者携带GLK 3'UTR体细胞变异(chr2:39 477 124 A>G),该变异增强T细胞中GLK mRNA水平,且携带者抗dsDNA升高、C3/C4降低;还鉴定出GLK A410T、K650R和A579T胚系变异,A410T和K650R通过抑制MKRN4介导的泛素化稳定GLK蛋白。结论为多种GLK胚系和体细胞变异通过增加mRNA或蛋白稳定性导致SLE患者中GLK诱导。
要点
- GLK 3'UTR体细胞变异chr2:39 477 124 A>G在58例SLE患者中频率较高,与抗dsDNA升高和C3/C4降低相关。
- GLK胚系变异A410T和K650R抑制MKRN4介导的泛素化,导致GLK蛋白稳定。
- 多种GLK变异通过增加mRNA或蛋白稳定性诱导GLK,参与SLE发病。
核心结论
- 多种GLK胚系和体细胞变异通过增加mRNA或蛋白稳定性导致SLE患者中GLK诱导。
研究设计与样本
- 研究纳入两个独立队列共181例SLE患者和250名非SLE个体(93名健康对照和157名SLE患者家属),对PBMC基因组DNA进行二代测序鉴定GLK基因变异。
- 采用定点诱变和细胞转染,结合报告基因试验、质谱、免疫印迹、免疫共沉淀和原位邻位连接试验研究GLK胚系或体细胞变异的功能后果。
主要发现
- 从队列#1和#2中鉴定出58例SLE患者携带GLK 3'UTR体细胞变异(chr2:39 477 124 A>G),这些患者血清抗双链DNA水平升高、血清C3/C4水平降低。
- 该3'UTR体细胞变异增强T细胞中GLK mRNA水平。
- 在队列#1和#2中鉴定出5例SLE患者携带GLK(A410T)胚系变异,在队列#1中鉴定出另外2例SLE患者携带GLK(K650R)胚系变异。
- 在队列#2的1例SLE患者中检测到另一种GLK胚系变异A579T。
- GLK(A410T)和GLK(K650R)突变体均抑制新型E3连接酶MKRN4诱导的GLK泛素化,导致GLK蛋白稳定。
关键数值与推荐
- GLK 3'UTR体细胞变异位点为chr2:39 477 124 A>G。
- GLK胚系变异包括A410T、K650R和A579T。
临床怎么用
- GLK 3'UTR体细胞变异(chr2:39 477 124 A>G)与SLE患者抗dsDNA升高和C3/C4降低相关,或可作为疾病活动性监测的候选标志物。
- GLK胚系变异A410T和K650R通过抑制MKRN4介导的泛素化稳定GLK蛋白,为SLE发病机制提供线索。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: MAP4K3 (GLK) overexpression in T cells induces interleukin (IL)-17A production and autoimmune responses. GLK overexpressing T-cell population is correlated with severity of human systemic lupus erythematosus (SLE); however, it is unclear how GLK is upregulated in patients with SLE. METHODS: We enrolled 181 patients with SLE and 250 individuals without SLE (93 healthy controls and 157 family members of patients with SLE) in two independent cohorts from different hospitals/cities. Genomic DNAs of peripheral blood mononuclear cells were subjected to next-generation sequencing to identify GLK gene variants. The functional consequences of the identified GLK germline or somatic variants were investigated using site-directed mutagenesis and cell transfection, followed by reporter assays, mass spectrometry, immunoblotting, coimmunoprecipitation, and in situ proximity ligation assays. RESULTS: We identified 58 patients with SLE from Cohort #1 and #2 with higher frequencies of a somatic variant (chr2:39 477 124 A>G) in GLK 3'-untranslated region (UTR); these patients with SLE showed increased serum anti-double-stranded DNA levels and decreased serum C3/C4 levels. This somatic variant in 3'-UTR enhanced GLK mRNA levels in T cells. In addition, we identified five patients with SLE with GLK (A410T) germline variant in Cohort #1 and #2, as well as two other patients with SLE with GLK (K650R) germline variant in Cohort #1. Another GLK germline variant, A579T, was also detected in one patient with SLE from Cohort #2. Both GLK (A410T) and GLK (K650R) mutants inhibited GLK ubiquitination induced by the novel E3 ligase makorin ring-finger protein 4 (MKRN4), leading to GLK protein stabilisation. CONCLUSIONS: Multiple GLK germline and somatic variants cause GLK induction by increasing mRNA or protein stability in patients with SLE.
引用
- Chuang HC, Hung WT, Chen YM, et al. Genomic sequencing and functional analyses identify MAP4K3/GLK germline and somatic variants associated with systemic lupus erythematosus. Ann Rheum Dis. 2021. PMID: 34610951. doi:10.1136/annrheumdis-2021-221010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。